Navigation Links
Luminex Corporation to Present at Jefferies 2012 Global Healthcare Conference
Date:5/30/2012

AUSTIN, Texas, May 30, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Jefferies 2012 Global Healthcare Conference to be held June 4-7 in New York.

(Logo:  http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 1:30 p.m. Eastern time on Wednesday, June 6, 2012.  The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.  Simply log on to the website, go to the About Us section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. We are transforming global healthcare and life-science research through the development, manufacturing, and marketing of proprietary instruments and assays utilizing our xMAP® open-architecture, multi-analyte platform and our MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies that deliver cost-effective and rapid results to clinicians and researchers. Our technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. We are meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug di
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Luminex Corporation Receives CE Mark for Revolutionary Newborn Screening Platform
2. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
3. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
4. Luminex Corporation to Present at JP Morgan Healthcare Conference
5. Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match®
6. ETEX Corporation to present at the 9th World Biomaterial Congress
7. Sigma-Aldrich Corporation Announces New Credit Facility
8. Verenium Corporation To Announce First Quarter 2012 Financial Results
9. China Cord Blood Corporation Announces Completion of $65 Million Convertible Debt Financing with KKR
10. ETEX Corporation to Present at GTC Stem Cell Summit
11. Psyche Systems Corporation Signs Strategic Alliance with Siemens Healthcare to Provide Anatomic Pathology Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- ARCH Venture Partners, one of the largest U.S. ... seed and early-stage advanced technology companies, today announced ... than $400 million in subscriptions. ARCH Venture Fund ... more than $150 million. "The enthusiasm ... of our approach to finding and funding new ...
(Date:8/27/2014)... After the boom of the energy drink ... craze is going to be the stress relief drinks. ... Stress Relief energy pattern which can be applied to ... beverage, including minerals, herbs and liquids. Stress Relief generates ... into rapid recovery and helping to adapt more quickly. ...
(Date:8/27/2014)... Hunting Valley, Ohio (PRWEB) August 27, 2014 ... five students from Cleveland's University School ... at Case Western Reserve University’s School of ... program provides students with an unparalleled professional experience ... with the School of Medicine faculty and students ...
(Date:8/26/2014)... 26, 2014 An analysis by Replikins, Ltd. ... Mers CoV virus strains has revealed extensive ... 2012.  This conservation and sharing of specific Replikin gene ... Blocker-Vaccine™ candidate, as it did for the H5N1 influenza ... which have been found to be effective (1,2). ...
Breaking Biology Technology:Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4Students at Cleveland's University School Conduct Biomedical Research at Case Western Reserve University’s School of Medicine 2
... Still Earn D,s or F,s on ... Legislation Report Card, WASHINGTON, March 11 For the ... laws that,require insurance providers to cover the cost of colon cancer screening,tests, according ... groups. The enactment of new coverage laws in five states,during 2007 also increased ...
... 11 Pressure,BioSciences, Inc. (Nasdaq: PBIO ) ... PBI,s senior executive management team as Vice President,of ... years of experience in,sales and sales management at ... will oversee PBI,s seven US-based, regional sales directors ...
... an Interferon-Beta Therapy, According to a New Report from Decision ... ... Mass., March 11 Decision Resources, one of the,world,s leading research ... Pharmaceutical,s Copaxone has the,greatest patient share among first- and second-line therapies, ...
Cached Biology Technology:Colon Cancer Screening Laws Now Cover Half of U.S. Population 2Colon Cancer Screening Laws Now Cover Half of U.S. Population 3Colon Cancer Screening Laws Now Cover Half of U.S. Population 4Colon Cancer Screening Laws Now Cover Half of U.S. Population 5Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales 2Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales 3Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales 4Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis 2Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis 3
(Date:8/27/2014)... NEW YORK , Aug. 27, 2014 /PRNewswire/ ... report is available in its catalogue: ... http://www.reportlinker.com/p02316674/Law-Enforcement-Biometrics-Market-in-North-America-2014-2018.html ... to assess individuals on the basis of their ... and identification of both physiological traits such as ...
(Date:8/27/2014)... easier when it only requires nerve cells to rearrange ... have to generate new patterns, a study of monkeys ... learn through recordings of electrical activity of brain cell ... Institutes of Health. , "We looked into the brain ... think outside the box," said Aaron Batista, Ph.D., an ...
(Date:8/27/2014)... LAKE CITY, Aug. 27, 2014 University of Utah ... his native Turkey, has won that nation,s highest science ... of Science. , Sekercioglu is among five researchers picked ... and Technical Research Council of Turkey. Three researchers won ... won the Special Award, which is equivalent to the ...
Breaking Biology News(10 mins):Law Enforcement Biometrics Market in North America 2014-2018 2Law Enforcement Biometrics Market in North America 2014-2018 3Law Enforcement Biometrics Market in North America 2014-2018 4Law Enforcement Biometrics Market in North America 2014-2018 5Scientists plug into a learning brain 2Scientists plug into a learning brain 3University of Utah biologist wins Turkey's top science prize 2
... Ill., Nov. 15 Corporate Safe Specialists (CSS),announces ... The,Company has hired Randy Biela, a software engineer, ... http://www.newscom.com/cgi-bin/prnh/20070119/CGF030LOGO ) Ed McGunn, President and CEO ... department of five full-time employees led by myself. ...
... dogs and humans display many of the same characteristics, ... breast cancer progression and prevention for people and pets, ... Veterinary Medicine. A group of scientists including Sulma ... considered to carry risk for developing breast cancer in ...
... do immobile organisms like plants cope when faced with ... question in light of new environmental conditions brought on ... study, published in the Nov. 16 issue of the ... setting as their maternal plant performed almost 3 times ...
Cached Biology News:Corporate Safe Specialists Announces Additions to R&D Team 2Purdue research finds similarities in dog, human breast cancer pre-malignant lesions 2Purdue research finds similarities in dog, human breast cancer pre-malignant lesions 3Purdue research finds similarities in dog, human breast cancer pre-malignant lesions 4Evolutionary biology research on plant shows significance of maternal effects 2
... the efficient enrichment of functional endoplasmic ... cell culture. The isolated ER are ... metabolic pathway analysis. Metabolic abnornalities of ... children, cystic fibrosis and many more ...
Plasmid expressing PLAP reporter gene....
Plasmid expressing the LacZ reporter gene....
Human SEAP ORF, provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
Biology Products: